Figure 3.
Grp78-treated CD11c+ cells retained a regulatory signature after proinflammatory stimulation by LPS in vitro. LPS was added for the final 18–24 h during cell culture to generate DCGrp78+LPS or DCLPS. (A) Flow cytometry analysis of MHC-II, CD83, CD80, and CD40 expression on DCGrp78+LPS and DCLPS cells. Mean fluorescence intensity and (upper), representative flow cytometric dot plots (middle), and percentage of positive cells (lower) were depicted. (B) Percentage of B7-H3/B7-H4/B7-H1/B7-DC cells in DCGrp78+LPS and DCLPS cells. (C) Endocytosis assessed by 1 h incubation with dextran-rhodamine. MFI (left) and percentage of rhodamine positive cells (right) were depicted. (D) Cell culture supernatants were analyzed for IL-10, TGF-β, TNF-α, NO, HMGB-1, and IFN-γ by ELISA. (E) Gene expression of COX-2, TGF-β, TNF-α, iNOS, and ARG-1 assessed by qPCR. All results were representative of three independent experiments. Error bars were presented in SEM. *P < 0.05 vs. DCLPS, **P < 0.01 vs. DCLPS.